NICOLE EVANKO: Open Payments
NPI 1184210122 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,760 in 113 payments from 14 companies in 2025. Trend: 2023 $97 · 2024 $1,938 · 2025 $2,760
Food & beverage: $2,649Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $539 |
| ABBVIE INC. | 13 | $469 |
| Neurocrine BioSciences, Inc. | 17 | $343 |
| Alkermes, Inc. | 13 | $339 |
| Janssen Pharmaceuticals, Inc | 8 | $302 |
| E.R. Squibb & Sons, L.L.C. | 20 | $225 |
| Otsuka America Pharmaceutical, Inc. | 11 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Indivior Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
Products named: VRAYLAR, INGREZZA, UZEDY, COBENFY, SPRAVATO, AUSTEDO XR, ABILIFY ASIMTUFII, LYBALVI.
Industry payments across CT — which companies pay providers there.
